{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:56:05Z","timestamp":1790654165495,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T00:00:00Z","timestamp":1227744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00259-008-0979-7","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T17:31:32Z","timestamp":1227720692000},"page":"428-435","source":"Crossref","is-referenced-by-count":75,"title":["Monoamine transporter availability in Parkinson\u2019s disease patients with or without depression"],"prefix":"10.1007","volume":"36","author":[{"given":"Swen","family":"Hesse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp M.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Strecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henryk","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Wegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Oehlwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis Ugo","family":"Isaias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,11,27]]},"reference":[{"key":"979_CR1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.286.2.154-JMN0711-2-1","volume":"286","author":"L Lamberg","year":"2001","unstructured":"Lamberg L. Psychiatric symptoms common in neurological disorders. JAMA 2001;286:154\u201356.","journal-title":"JAMA"},{"issue":"Suppl 6","key":"979_CR2","first-page":"VI\/24","volume":"251","author":"MR Lemke","year":"2004","unstructured":"Lemke MR, Fuchs G, Gemende I, Herting B, Oehlwein C, Reichmann H, et al. Depression and Parkinson\u2019s disease. J Neurol 2004;251(Suppl 6):VI\/24\u2013VI\/27.","journal-title":"J Neurol"},{"key":"979_CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","volume":"13","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Stern MB. Psychiatric complications in Parkinson disease. Am J Geriatr Psychiatry 2005;13:844\u201351.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"Suppl 4","key":"979_CR4","first-page":"IV\/2","volume":"247","author":"T Br\u00fccke","year":"2000","unstructured":"Br\u00fccke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I. SPECT and PET imaging of the dopaminergic system in Parkinson\u2019s disease. J Neurol 2000;247(Suppl 4):IV\/2\u2013IV\/7.","journal-title":"J Neurol"},{"key":"979_CR5","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.biopsych.2006.03.004","volume":"59","author":"VL Cropley","year":"2006","unstructured":"Cropley VL, Fujita M, Innis RB, Nathan PJ. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol Psychiatry 2006;59:898\u2013907.","journal-title":"Biol Psychiatry"},{"key":"979_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-510X(95)00146-S","volume":"133","author":"LG Chia","year":"1995","unstructured":"Chia LG, Cheng LJ, Chuo LJ, Cheng FC, Cu JS. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolites in patients with Parkinson\u2019s disease. J Neurol Sci 1995;133:73\u20138.","journal-title":"J Neurol Sci"},{"key":"979_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1353-8020(03)00108-1","volume":"10","author":"TH Chung","year":"2003","unstructured":"Chung TH, Deane KH, Ghazi-Noori S, Rickards H, Clarke CE. Systematic review of antidepressant therapies in Parkinson\u2019s disease. Parkinsonism Relat Disord 2003;10:59\u201365.","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 3","key":"979_CR8","doi-asserted-by":"crossref","first-page":"III5","DOI":"10.1007\/PL00022917","volume":"248","author":"M Yamamoto","year":"2001","unstructured":"Yamamoto M. Depression in Parkinson\u2019s disease: its prevalence, diagnosis, and neurochemical background. J Neurol 2001;248(Suppl 3):III5\u2013III11.","journal-title":"J Neurol"},{"key":"979_CR9","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp.63.5.590","volume":"63","author":"T Becker","year":"1997","unstructured":"Becker T, Becker G, Seufert J, Hofmann E, Lange KW, Naumann M, et al. Parkinson\u2019s disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997;63:590\u201396.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"979_CR10","doi-asserted-by":"crossref","unstructured":"M\u00f6ssner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP. The serotonin transporter in Alzheimer\u2019s and Parkinson\u2019s disease. J Neural Transm Suppl 2000:345\u201350.","DOI":"10.1007\/978-3-7091-6301-6_24"},{"issue":"Suppl 1","key":"979_CR11","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.parkreldis.2004.02.002","volume":"10","author":"KA Sawabini","year":"2004","unstructured":"Sawabini KA, Watts RL. Treatment of depression in Parkinson\u2019s disease. Parkinsonism Relat Disord 2004;10(Suppl 1):S37\u2013S41.","journal-title":"Parkinsonism Relat Disord"},{"key":"979_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1460-9568.2006.04900.x","volume":"24","author":"C Wersinger","year":"2006","unstructured":"Wersinger C, Rusnak M, Sidhu A. Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci 2006;24:55\u201364.","journal-title":"Eur J Neurosci"},{"key":"979_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00702-005-0368-3","volume":"113","author":"B Scholtissen","year":"2006","unstructured":"Scholtissen B, Verhey FR, Steinbusch HW, Leentjens AF. Serotonergic mechanisms in Parkinson\u2019s disease: opposing results from preclinical and clinical data. J Neural Transm 2006;113:59\u201373.","journal-title":"J Neural Transm"},{"key":"979_CR14","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biopsych.2005.12.017","volume":"59","author":"DJ Brooks","year":"2006","unstructured":"Brooks DJ, Piccini P. Imaging in Parkinson\u2019s disease: the role of monoamines in behavior. Biol Psychiatry 2006;59:908\u201318.","journal-title":"Biol Psychiatry"},{"key":"979_CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/appi.neuropsych.13.2.222","volume":"13","author":"T Murai","year":"2001","unstructured":"Murai T, M\u00fcller U, Werheid K, Sorger D, Reuter M, Becker T, et al. In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 2001;13:222\u201328.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"979_CR16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2004.08.004","volume":"28","author":"S Hesse","year":"2004","unstructured":"Hesse S, Barthel H, Schwarz J, Sabri O, M\u00fcller U. Advances in in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev 2004;28:547\u201363.","journal-title":"Neurosci Biobehav Rev"},{"key":"979_CR17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/jm9505324","volume":"39","author":"JL Neumeyer","year":"1996","unstructured":"Neumeyer JL, Tamagnan G, Wang S, Gao Y, Milius RA, Kula NS, et al. N-substituted analogs of 2\u03b2-carbomethoxy-3\u03b2-(4\u2032-iodophenyl)tropane (\u03b2-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain. J Med Chem 1996;39:543\u201348.","journal-title":"J Med Chem"},{"key":"979_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0969-8051(97)00156-X","volume":"25","author":"T Okada","year":"1998","unstructured":"Okada T, Fujita M, Shimada S, Sato K, Schloss P, Watanabe Y, et al. Assessment of affinities of \u03b2-CIT, \u03b2-CIT-FE, and \u03b2-CIT-FP for monoamine transporters permanently expressed in cell lines. Nucl Med Biol 1998;25:53\u20138.","journal-title":"Nucl Med Biol"},{"key":"979_CR19","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/S0960-894X(01)00626-6","volume":"11","author":"XH Gu","year":"2001","unstructured":"Gu XH, Zong R, Kula NS, Baldessarini RJ, Neumeyer JL. Synthesis and biological evaluation of a series of novel N- or O-fluoroalkyl derivatives of tropane: potential positron emission tomography (PET) imaging agents for the dopamine transporter. Bioorg Med Chem Lett 2001;11:3049\u201353.","journal-title":"Bioorg Med Chem Lett"},{"key":"979_CR20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-0348-8391-7_3","volume":"54","author":"B Olivier","year":"2000","unstructured":"Olivier B, Soudijn W, van Wijngaarden I. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Prog Drug Res 2000;54:59\u2013119.","journal-title":"Prog Drug Res"},{"key":"979_CR21","first-page":"839","volume":"44","author":"PT Meyer","year":"2003","unstructured":"Meyer PT, Sattler B, Lincke T, Seese A, Sabri O. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems. J Nucl Med 2003;44:839\u201345.","journal-title":"J Nucl Med"},{"key":"979_CR22","first-page":"359","volume":"48","author":"J Booij","year":"2007","unstructured":"Booij J, de Jong J, de Bruin K, Knol R, de Win MM, van Eck-Smit BL. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects. J Nucl Med 2007;48:359\u201366.","journal-title":"J Nucl Med"},{"key":"979_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1993","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1993;55:181\u201384.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"979_CR24","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1995","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1995.","edition":"4"},{"key":"979_CR25","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","volume":"66","author":"JM Miyasaki","year":"2006","unstructured":"Miyasaki JM, Shannon K, Voon V, Ravina B, Kleiner-Fisman G, Anderson K, et al.; Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006;66:996\u20131002.","journal-title":"Neurology"},{"key":"979_CR26","first-page":"165","volume-title":"Clinical gerontology: a guide to assessment and intervention","author":"JI Sheikh","year":"1986","unstructured":"Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In: Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York: The Haworth Press; 1986. p. 165\u201373"},{"key":"979_CR27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s001170050845","volume":"40","author":"H Barthel","year":"2000","unstructured":"Barthel H, M\u00fcller U, W\u00e4chter T, Slomka P, Dannenberg C, Murai T, et al. Multimodal SPECT and MRT imaging data analysis for an improvement in the diagnosis of idiopathic Parkinson\u2019s syndrome (in German). Radiologe 2000;40:863\u201369.","journal-title":"Radiologe"},{"key":"979_CR28","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-005-0401-6","volume":"113","author":"S Hesse","year":"2006","unstructured":"Hesse S, Oehlwein C, Barthel H, Schwarz J, Polster D, Wagner A, et al. Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome. J Neural Transm 2006;113:1177\u201390.","journal-title":"J Neural Transm"},{"key":"979_CR29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00259-002-1044-6","volume":"30","author":"S Hesse","year":"2003","unstructured":"Hesse S, Barthel H, Murai T, M\u00fcller U, M\u00fcller D, Seese A, et al. Is correction for age necessary in neuroimaging studies of the central serotonin transporter? Eur J Nucl Med Mol Imaging 2003;30:427\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"979_CR30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s002590000279","volume":"27","author":"J Lavalaye","year":"2000","unstructured":"Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med 2000;27:867\u201369.","journal-title":"Eur J Nucl Med"},{"key":"979_CR31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-5415.2004.52219.x","volume":"52","author":"D Weintraub","year":"2004","unstructured":"Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other non-motor symptoms on disability in Parkinson\u2019 disease. J Am Geriatr Soc 2004;52:784\u201388.","journal-title":"J Am Geriatr Soc"},{"key":"979_CR32","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1212\/01.WNL.0000165958.12724.0D","volume":"64","author":"S Holroyd","year":"2005","unstructured":"Holroyd S, Currie LJ, Wooten F. Depression is associated with impairment of ADL, not motor function in Parkinson disease. Neurology 2005;64:2134\u201335.","journal-title":"Neurology"},{"key":"979_CR33","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1097\/00001756-200112210-00052","volume":"12","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Kruger S, Wilson AA, Christensen BK, Goulding VS, Schaffer A, et al. Lower dopamine transporter binding potential in striatum during depression. Neuroreport 2001;12:4121\u201325.","journal-title":"Neuroreport"},{"issue":"Suppl 2","key":"979_CR34","first-page":"S228","volume":"31","author":"S Hesse","year":"2004","unstructured":"Hesse S, Schwarz J, Polster D, Strecker K, Sabri O. Dopaminergic hypofunction in parkinsonian patients with neuropsychiatric symptoms exceeds the degeneration of nigrostriatal neurons as expected by their motor impairment. Eur J Nucl Med Mol Imaging 2004;31(Suppl 2):S228.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"979_CR35","first-page":"A82","volume":"43","author":"S Hesse","year":"2004","unstructured":"Hesse S, Schwarz J, Polster D, Isaias IU, Peschel S, Wagner A, et al. Schweregrad und Symmetrie der nigrostriatalen dopaminergen Neurodegeneration kennzeichnen neuropsychiatrische Symptome bei Parkinson-Patienten. Nuklearmedizin 2004;43:A82.","journal-title":"Nuklearmedizin"},{"issue":"Suppl 10","key":"979_CR36","first-page":"P142","volume":"20","author":"IU Isaias","year":"2005","unstructured":"Isaias IU, Hesse S, Benti R, Zini M, Schwarz J, Antonini A. Relationship between non-motor signs and asymmetry of striatal transporter (DAT) loss in patients with early Parkinson\u2019s disease measured with SPECT and (123I)Ioflupane. Mov Disord 2005;20(Suppl 10):P142.","journal-title":"Mov Disord"},{"issue":"Suppl","key":"979_CR37","first-page":"393","volume":"44","author":"S Hesse","year":"2003","unstructured":"Hesse S, Schwarz J, Oehlwein C, Tietze F, Lincke T, Eggers B, et al. Different patterns of dopaminergic nerve cell degeneration in Parkinson\u2019s disease. J Nucl Med 2003;44(Suppl):393.","journal-title":"J Nucl Med"},{"key":"979_CR38","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","volume":"114","author":"J Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Samnick S, Jost W, M\u00f6llers MO, Fassbender K, et al. Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease. J Neural Transm 2007;114:331\u201335.","journal-title":"J Neural Transm"},{"issue":"Suppl","key":"979_CR39","first-page":"S156","volume":"30","author":"S Hesse","year":"2003","unstructured":"Hesse S, Lincke T, Hermann W, Oehlwein C, Tietze F, Schwarz J, et al. Asymmetry of presynaptic dopaminergic nerve cell degeneration is attributed to tremor-associated Parkinson\u2019s disease (PD) but not to hypokinetic syndromes \u2013 an iodine-123-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging 2003;30(Suppl):S156.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"979_CR40","first-page":"S373","volume":"31","author":"S Hesse","year":"2004","unstructured":"Hesse S, Schwarz J, Strecker K, Polster D, Isaias IU, Meixensberger J, et al. The severity of striatal dopaminergic hypofunction and the degree of neuropsychiatric impairment did not correlate with each other in parkinsonian patients. Eur J Nucl Med Mol Imaging 2004;31(Suppl 2):S373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"979_CR41","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/WNR.0b013e3282ef69f9","volume":"18","author":"IU Isaias","year":"2007","unstructured":"Isaias IU, Benti R, Cilia R, Canesi M, Marotta G, Gerundini P, et al. [123I]FP-CIT striatal binding in early Parkinson\u2019s disease patients with tremor vs. akinetic-rigid onset. Neuroreport 2007;18:1499\u20131502.","journal-title":"Neuroreport"},{"key":"979_CR42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00702-007-0015-2","volume":"115","author":"V Caretti","year":"2008","unstructured":"Caretti V, Stoffers D, Winogrodzka A, Isaias IU, Costantino G, Pezzoli G, et al. Loss of thalamic serotonin transporters in early drug-na\u00efve Parkinson\u2019s disease patients is associated with tremor: an [123I]beta-CIT SPECT study. J Neural Transm 2008;115:721\u201329.","journal-title":"J Neural Transm"},{"key":"979_CR43","first-page":"227","volume":"46","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson\u2019s disease. J Nucl Med 2005;46:227\u201332.","journal-title":"J Nucl Med"},{"key":"979_CR44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-0038-1623903","volume":"42","author":"G Berding","year":"2003","unstructured":"Berding G, Br\u00fccke T, Odin P, Brooks DJ, Kolbe H, Gielow P, et al. [123I]\u03b2-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson\u2019s disease and multiple system atrophy. Nuklearmedizin 2003;42:31\u201338.","journal-title":"Nuklearmedizin"},{"key":"979_CR45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","volume":"60","author":"L Kerenyi","year":"2003","unstructured":"Kerenyi L, Ricaurte GA, Schretlen DJ, McCann U, Varga J, Mathews WB, et al. Positron emission tomography of striatal serotonin transporters in Parkinson disease. Arch Neurol 2003;60:1223\u201329.","journal-title":"Arch Neurol"},{"key":"979_CR46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1468-1331.2007.01727.x","volume":"14","author":"M Guttman","year":"2007","unstructured":"Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, et al. Brain serotonin transporter binding in non-depressed patients with Parkinson\u2019s disease. Eur J Neurol 2007;14:523\u201328.","journal-title":"Eur J Neurol"},{"key":"979_CR47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.jcbfm.9600599","volume":"28","author":"RL Albin","year":"2008","unstructured":"Albin RL, Koeppe RA, Bohnen NI, Wernette K, Kilbourn MA, Frey KA. Spared caudal brainstem SERT binding in early Parkinson\u2019s disease. J Cereb Blood Flow Metab 2008;28:441\u201344.","journal-title":"J Cereb Blood Flow Metab"},{"key":"979_CR48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1176\/appi.ajp.163.1.52","volume":"163","author":"RV Parsey","year":"2006","unstructured":"Parsey RV, Hastings RS, Oquendo MA, Huang YY, Simpson N, Arcement J, et al. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am J Psychiatry 2006;163:52\u201358.","journal-title":"Am J Psychiatry"},{"key":"979_CR49","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.pnpbp.2006.03.019","volume":"30","author":"S Lehto","year":"2006","unstructured":"Lehto S, Tolmunen T, Joensuu M, Saarinen PI, Vanninen R, Ahola P, et al. Midbrain binding of [123I]nor-\u03b2-CIT in atypical depression. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1251\u201355.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"979_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0197-4580(01)00269-X","volume":"23","author":"U Rub","year":"2002","unstructured":"Rub U, Del Tredici K, Schultz C, Ghebremedhin E, de Vos RA, Jansen Steur E, et al. Parkinson\u2019s disease: the thalamic components of the limbic loop are severely impaired by \u03b1-synuclein immunopositive inclusion body pathology. Neurobiol Aging 2002;23:245\u201354.","journal-title":"Neurobiol Aging"},{"issue":"Suppl 6","key":"979_CR51","first-page":"3","volume":"67","author":"DJ Nutt","year":"2006","unstructured":"Nutt DJ. The role of dopamine and norepinephrine in depression and antidepressant treatment. Clin Psychiatry 2006;67(Suppl 6):3\u20138.","journal-title":"Clin Psychiatry"},{"key":"979_CR52","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005;128:1314\u201322.","journal-title":"Brain"},{"key":"979_CR53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag A, Barone P, Brown RG, Leentjens AF, McDonald WM, Starkstein S, et al. Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 2007;22:1077\u201392.","journal-title":"Mov Disord"},{"key":"979_CR54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1176\/ajp.154.4.490","volume":"154","author":"GS Smith","year":"1997","unstructured":"Smith GS, Dewey SL, Brodie JD, Logan J, Vitkun SA, Simkowitz P, et al. Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects. Am J Psychiatry 1997;154:490\u201396.","journal-title":"Am J Psychiatry"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0979-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-008-0979-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-0979-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T14:12:26Z","timestamp":1684678346000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-008-0979-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,27]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1007\/s00259-008-0979-7","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,27]]}}}